Gout and risk of Parkinson disease -: A prospective study

被引:135
作者
Alonso, Alvaro
Garcia Rodriguez, Luis A.
Logroscino, Giancarlo
Hernan, Miguel A.
机构
[1] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[2] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
关键词
D O I
10.1212/01.wnl.0000279518.10072.df
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Several reports suggest that higher levels of serum uric acid are associated with a lower risk of Parkinson disease ( PD). None of these studies, however, evaluated the potential association between gout, a condition characterized by hyperuricemia, and the risk of PD. Objective: To estimate prospectively the association between gout diagnosis and the risk of PD. Methods: We conducted a case- control study nested in the General Practice Research Database, a computerized database that gathers information on more than 3 million Britons followed up by their general practitioners. PD cases occurring between January 1995 and December 2001 were identified, and matched with up to 10 controls by sex, age, practice, and start of follow- up. We obtained information on history of gout and use of anti- gout medication using the computerized medical records. Results: During the study period, we identified 1,052 PD cases and 6,634 controls. Individuals with previous history of gout had a lower risk of developing PD ( OR 0.69, 95% CI 0.48, 0.99). This association was evident among men ( OR 0.60, 95% CI 0.40, 0.91) but not among women ( OR 1.26, 95% CI 0.57, 2.81; p for interaction: 0.11). Initiation of anti- gout medication was associated with a lower risk of PD ( OR 0.57, 95% CI 0.19, 1.70). Conclusion: Gout is associated with a lower risk of Parkinson disease ( PD). Our findings provide additional support for a potential link between uric acid and PD. Further research is required to explore a potential effect modification by sex.
引用
收藏
页码:1696 / 1700
页数:5
相关论文
共 30 条
  • [1] Dopamine and uric acid act as antioxidants in the repair of DNA radicals: Implications in Parkinson's disease
    Anderson, RF
    Harris, TA
    [J]. FREE RADICAL RESEARCH, 2003, 37 (10) : 1131 - 1136
  • [2] Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
    Ascherio, A
    Zhang, SMM
    Hernán, MA
    Kawachi, I
    Colditz, GA
    Speizer, FE
    Willett, WC
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (01) : 56 - 63
  • [3] ASCHERIO A, 2006, 10 INT C PARK DIS MO
  • [4] Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341
  • [5] URIC-ACID IS REDUCED IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE - EFFECT ON DOPAMINE OXIDATION
    CHURCH, WH
    WARD, VL
    [J]. BRAIN RESEARCH BULLETIN, 1994, 33 (04) : 419 - 425
  • [6] Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease
    Davis, JW
    Grandinetti, A
    Waslien, CI
    Ross, GW
    White, LR
    Morens, DM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (05) : 480 - 484
  • [7] Serum uric acid levels and the risk of Parkinson disease
    de Lau, LML
    Koudstaal, PJ
    Hofman, A
    Breteler, MMB
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (05) : 797 - 800
  • [8] Serum cholesterol levels and the risk of Parkinson's disease
    de lau, Lonneke M. L.
    Koudstaal, Peter J.
    Hofman, Albert
    Breteler, Monique M. B.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (10) : 998 - 1002
  • [9] Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic, neurons in models of Parkinson's disease
    Duan, W
    Ladenheim, B
    Cutler, RG
    Kruman, II
    Cadet, JL
    Mattson, MP
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (01) : 101 - 110
  • [10] EFFECTS OF SMOKING AND VITAMIN-E ON BLOOD ANTIOXIDANT STATUS
    DUTHIE, GG
    ARTHUR, JR
    JAMES, WPT
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (04) : S1061 - S1063